4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001600620-26-000003
Chief Financial Officer gave up 40,161 shares (to pay taxes)
- Chief Financial Officer acquired 49,038 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Miller Joseph M · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 1 in the form | +49,038 | 626,399 | D | ||
| 2026-01-02 | Shares withheld for taxes : show line 2 in the form | −40,161 | $15.95 | $640,568 | 589,127 | D |
Loading xslF345X05/wk-form4_1767647470.xml…